|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 28879 |
FusionGeneSummary for PRPF4B_F13A1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: PRPF4B_F13A1 | Fusion gene ID: 28879 | Hgene | Tgene | Gene symbol | PRPF4B | F13A1 | Gene ID | 8899 | 2162 |
| Gene name | pre-mRNA processing factor 4B | coagulation factor XIII A chain | |
| Synonyms | PR4H|PRP4|PRP4H|PRP4K|dJ1013A10.1 | F13A | |
| Cytomap | 6p25.2 | 6p25.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | serine/threonine-protein kinase PRP4 homologPRP4 kinasePRP4 pre-mRNA processing factor 4 homolog BPRP4 pre-mRNA-processing factor 4 homologdJ1013A10.1 (PRP4 protein kinase homolog)protein-serine/threonine kinase | coagulation factor XIII A chainFSF, A subunitTGasebA525O21.1 (coagulation factor XIII, A1 polypeptide)coagulation factor XIII, A polypeptidecoagulation factor XIII, A1 polypeptidecoagulation factor XIIIafactor XIIIafibrin stabilizing factor, A sub | |
| Modification date | 20180523 | 20180519 | |
| UniProtAcc | Q13523 | P00488 | |
| Ensembl transtripts involved in fusion gene | ENST00000494674, ENST00000337659, ENST00000538861, | ENST00000264870, | |
| Fusion gene scores | * DoF score | 4 X 2 X 5=40 | 6 X 5 X 4=120 |
| # samples | 5 | 6 | |
| ** MAII score | log2(5/40*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(6/120*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: PRPF4B [Title/Abstract] AND F13A1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | F13A1 | GO:0018149 | peptide cross-linking | 27363989 |
| Tgene | F13A1 | GO:0072378 | blood coagulation, fibrin clot formation | 27363989 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | SKCM | TCGA-GN-A264-06A | PRPF4B | chr6 | 4021700 | + | F13A1 | chr6 | 6197559 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000494674 | ENST00000264870 | PRPF4B | chr6 | 4021700 | + | F13A1 | chr6 | 6197559 | - |
| In-frame | ENST00000337659 | ENST00000264870 | PRPF4B | chr6 | 4021700 | + | F13A1 | chr6 | 6197559 | - |
| intron-3CDS | ENST00000538861 | ENST00000264870 | PRPF4B | chr6 | 4021700 | + | F13A1 | chr6 | 6197559 | - |
Top |
FusionProtFeatures for PRPF4B_F13A1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| PRPF4B | F13A1 |
| Has a role in pre-mRNA splicing. Phosphorylates SF2/ASF. | Factor XIII is activated by thrombin and calcium ion toa transglutaminase that catalyzes the formation of gamma-glutamyl-epsilon-lysine cross-links between fibrin chains, thus stabilizingthe fibrin clot. Also cross-link alpha-2-plasmin inhibitor, orfibronectin, to the alpha chains of fibrin.{ECO:0000269|PubMed:27363989}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for PRPF4B_F13A1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| >In-frame_PRPF4B_ENST00000337659_chr6_4021700_+_F13A1_ENST00000264870_chr6_6197559_-_376aa MAAAETQSLREQPENYHCWNEAWMTRPDLPVGFGGWQAVDSTPQENSDGMYRCGPASVQAIKHGHVCFQFDAPFVFAEVNSDLIYITAKK DGTHVVENVDATHIGKLIVTKQIGGDGMMDITDTYKFQEGQEEERLALETALMYGAKKPLNTEGVMKSRSNVDMDFEVENAVLGKDFKLS ITFRNNSHNRYTITAYLSANITFYTGVPKAEFKKETFDVTLEPLSFKKEAVLIQAGEYMGQLLEQASLHFFVTARINETRDVLAKQKSTV LTIPEIIIKVRGTQVVGSDMTVTVEFTNPLKETLRNVWVHLDGPGVTRPMKKMFREIRPNSTVQWEEVCRPWVSGHRKLIASMSSDSLRH |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| >In-frame_PRPF4B_ENST00000337659_chr6_4021700_+_F13A1_ENST00000264870_chr6_6197559_-_1128nt ATGGCCGCCGCGGAGACCCAGTCGCTACGGGAGCAGCCAGAGAACTACCACTGCTGGAATGAAGCATGGATGACAAGGCCTGACCTTCCT GTTGGATTTGGAGGCTGGCAAGCTGTGGACAGCACCCCCCAGGAAAATAGCGATGGCATGTATCGGTGTGGCCCCGCCTCGGTTCAAGCC ATCAAGCACGGCCATGTCTGCTTCCAATTTGATGCACCTTTTGTTTTTGCAGAGGTCAACAGCGACCTCATTTACATTACAGCTAAGAAA GATGGCACTCATGTGGTGGAAAATGTGGATGCCACCCACATTGGGAAATTAATTGTGACCAAACAAATTGGAGGAGATGGCATGATGGAT ATTACTGATACTTACAAATTCCAAGAAGGTCAAGAAGAAGAGAGATTGGCCCTAGAAACTGCCCTGATGTACGGAGCTAAAAAGCCCCTC AACACAGAAGGTGTCATGAAATCAAGGTCCAACGTTGACATGGACTTTGAAGTGGAAAATGCTGTGCTGGGAAAAGACTTCAAGCTCTCC ATCACCTTCCGGAACAACAGCCACAACCGTTACACCATCACAGCTTATCTCTCAGCCAACATCACCTTCTACACCGGGGTCCCGAAGGCA GAATTCAAGAAGGAGACGTTCGACGTGACGCTGGAGCCCTTGTCCTTCAAGAAAGAGGCGGTGCTGATCCAAGCCGGCGAGTACATGGGT CAGCTGCTGGAACAAGCGTCCCTGCACTTCTTTGTCACAGCTCGCATCAATGAGACCAGGGATGTTCTGGCCAAGCAAAAGTCCACCGTG CTAACCATCCCTGAGATCATCATCAAGGTCCGTGGCACTCAGGTAGTTGGTTCTGACATGACTGTGACAGTTGAGTTTACCAATCCTTTA AAAGAAACCCTGCGAAATGTCTGGGTACACCTGGATGGTCCTGGAGTAACAAGACCAATGAAGAAGATGTTCCGTGAAATCCGGCCCAAC TCCACCGTGCAGTGGGAAGAAGTGTGCCGGCCCTGGGTCTCTGGGCATCGGAAGCTGATAGCCAGCATGAGCAGTGACTCCCTGAGACAT |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_PRPF4B_ENST00000337659_chr6_4021700_+_F13A1_ENST00000264870_chr6_6197559_-_2762nt GGCACATGCGCGGCAGCTCTTTTCCTTCTTCCTCCACTTCCCCTACCCTCCACCGTCCGGGAGCCGCCGCCACCGCCGCCGAGGAGTCAG GAAGTTCAAGATGGCCGCCGCGGAGACCCAGTCGCTACGGGAGCAGCCAGAGAACTACCACTGCTGGAATGAAGCATGGATGACAAGGCC TGACCTTCCTGTTGGATTTGGAGGCTGGCAAGCTGTGGACAGCACCCCCCAGGAAAATAGCGATGGCATGTATCGGTGTGGCCCCGCCTC GGTTCAAGCCATCAAGCACGGCCATGTCTGCTTCCAATTTGATGCACCTTTTGTTTTTGCAGAGGTCAACAGCGACCTCATTTACATTAC AGCTAAGAAAGATGGCACTCATGTGGTGGAAAATGTGGATGCCACCCACATTGGGAAATTAATTGTGACCAAACAAATTGGAGGAGATGG CATGATGGATATTACTGATACTTACAAATTCCAAGAAGGTCAAGAAGAAGAGAGATTGGCCCTAGAAACTGCCCTGATGTACGGAGCTAA AAAGCCCCTCAACACAGAAGGTGTCATGAAATCAAGGTCCAACGTTGACATGGACTTTGAAGTGGAAAATGCTGTGCTGGGAAAAGACTT CAAGCTCTCCATCACCTTCCGGAACAACAGCCACAACCGTTACACCATCACAGCTTATCTCTCAGCCAACATCACCTTCTACACCGGGGT CCCGAAGGCAGAATTCAAGAAGGAGACGTTCGACGTGACGCTGGAGCCCTTGTCCTTCAAGAAAGAGGCGGTGCTGATCCAAGCCGGCGA GTACATGGGTCAGCTGCTGGAACAAGCGTCCCTGCACTTCTTTGTCACAGCTCGCATCAATGAGACCAGGGATGTTCTGGCCAAGCAAAA GTCCACCGTGCTAACCATCCCTGAGATCATCATCAAGGTCCGTGGCACTCAGGTAGTTGGTTCTGACATGACTGTGACAGTTGAGTTTAC CAATCCTTTAAAAGAAACCCTGCGAAATGTCTGGGTACACCTGGATGGTCCTGGAGTAACAAGACCAATGAAGAAGATGTTCCGTGAAAT CCGGCCCAACTCCACCGTGCAGTGGGAAGAAGTGTGCCGGCCCTGGGTCTCTGGGCATCGGAAGCTGATAGCCAGCATGAGCAGTGACTC CCTGAGACATGTGTATGGCGAGCTGGACGTGCAGATTCAAAGACGACCTTCCATGTGAATGCACAGGAAGCTGAGATGAACCCTGGCATT TGGCCTCTTGTAGTCTTGGCTAAGGAAATTCTAACGCAAAAATAGCTCTTGCTTTGACTTAGGTGTGAAGACCCAGACAGGACTGCAGAG GGCTCCAGAGTGGAGATCCCACATATTTCAAAAACATGCTTTTCCAAACCCAGGCTATTCGGCAAGGAAGTTAGTTTTTAATCTCTCCAC CTTCCAAAGAGTGCTAAGCATTAGCTTTAATTAAGCTCTCATAGCTCATAAGAGTAACAGTCATCATTTATCATCACAAATGGCTACATC TCCAAATATCAGTGGGCTCTCTTACCAGGGAGATTTGCTCAATACCTGGCCTCATTTAAAACAAGACTTCAGATTCCCCACTCAGCCTTT TGGGAATAATAGCACATGATTTGGGCTCTAGAATTCCAGTCCCCTTTCTCGGGGTCAGGTTCTACCCTCCATGTGAGAATATTTTTCCCA GGACTAGAGCACAACATAATTTTTATTTTTGGCAAAGCCAGAAAAAGATCTTTCATTTTGCACCTGCAGCCAAGCAAATGCCTGCCAAAT TTTAGATTTACCTTGTTAGAAGAGGTGGCCCCATATTAACAAATTGCATTTGTGGGAAACTTAACCACCTACAAGGAGATAAGAAAGCAG GTGCAACACTCAAGTCTATTGAATAATGTAGTTTTGTGATGCATTTTATAGAATGTGTCACACTGTGGCCTGATCAGCAGGAGCCAATAT CCCTTACTTTAACCCTTTCTGGGATGCAATACTAGGAAGTAAAGTGAAGAATTTATCTCTTTAGTTAGTGATTATATTTCACCCATCTCT CAGGAATCATCTCCTTTGCAGAATGATGCAGGTTCAGGTCCCCTTTCAGAGATATAATAAGCCCAACAAGTTGAAGAAGCTGGCGGATCT AGTGACCAGATATATAGAAGGACTGCAGCCACTGATTCTCTCTTGTCCTTCACATCACCCATGTTGAGACCTCAGCTTGGCACTCAGGTG CTGAAGGGTAATATGGACTCAGCCTTGCAAATAGCCAGTGCTAGTTCTGACCCAACCACAGAGGATGCTGACATCATTTGTATTATGTTC CAAGGCTACTACAGAGAAGGCTGCCTGCTATGTATTTGCAAGGCTGATTTATGGTCAGAATTTCCCTCTGATATGTCTAGGGTGTGATTT AGGTCAGTAGACTGTGATTCTTAGCAAAAAATGAACAGTGATAAGTATACTGGGGGCAAAATCAGAATGGAATGCTCTGGTCTATATAAC CACATTTCTAAGCCTTTGAGACTGTTCCTGAGCCTTCAGCACTAACCTATGAGGGTGAGCTGGTCCCCTCTATATATACATCATACTTAA CTTTACTAAGTAATCTCACAGCATTTGCCAAGTCTCCCAATATCCAATTTTAAAATGAAATGCATTTTGCTAGACAGTTAAACTGGCTTA |
Top |
FusionGenePPI for PRPF4B_F13A1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| PRPF4B | RNPS1, YWHAG, POLR3F, HSPB3, PNN, RRP1B, USP39, PRPF4, ARRB2, SIRT7, PRPF8, EFTUD2, SUPT16H, RPS11, RPL5, ESR1, MAGOH, SRPK2, SRPK3, MAPK12, SRRM2, PRPF6, SNRNP200, DDX23, SART1, SNRNP40, PRPF31, SNRPB, SNRPD1, NUDT21, SHFM1, OBSL1, RPL14, NIFK, ZRANB2, LUC7L, LUC7L2, EPB41L3, NTRK1, CLK1, SRSF1, CCDC67, XPO1, HSP90AA1, PRKCD, AKAP5, KIF1C, FAN1, NCBP2, CDC5L, ZC3H18, HIST1H1T, RPS14, RBM34, C11orf57, ZNF2, H2AFY2, CLK2, CD2BP2 | F13A1 | F13A1, F13B, FN1, FGA, NUDT21, UFD1L, SH3GL2, TK1, PTK2, CDKN1A, ANXA7 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for PRPF4B_F13A1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Tgene | F13A1 | P00488 | DB13151 | Anti-inhibitor coagulant complex | Coagulation factor XIII A chain | biotech | approved|investigational |
Top |
RelatedDiseases for PRPF4B_F13A1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | F13A1 | C2750514 | Factor Xiii, A Subunit, Deficiency Of | 3 | CTD_human;UNIPROT |
| Tgene | F13A1 | C0015530 | Factor XIII Deficiency | 1 | CTD_human |
| Tgene | F13A1 | C0027051 | Myocardial Infarction | 1 | CTD_human |
| Tgene | F13A1 | C0042487 | Venous Thrombosis | 1 | CTD_human |
| Tgene | F13A1 | C0162820 | Dermatitis, Allergic Contact | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|